The use of brincidofovir for the treatment of mixed dsDNA viral infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of brincidofovir for the treatment of mixed dsDNA viral infection

Published:2016-10 Issue: Volume:83 Page:1-4
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Camargo Jose F.,Morris Michele I.,Abbo Lilian M.,Simkins Jacques,Saneeymehri Seyyedeh,Alencar Maritza C.,Lekakis Lazaros J.,Komanduri Krishna V.

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference18 articles.

1. EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT;Rasche;Bone Marrow Transplant.,2014

2. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;Biol. Blood Marrow Transplant.,2009

3. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity;Boeckh;Blood,2003

4. Adenovirus infections in transplant recipients;Ison;Clin. Infect. Dis.,2006

5. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro;Williams-Aziz;Antimicrob. Agents Chemother.,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes;Viruses;2024-08-14

2. Brincidofovir inhibits polyomavirus infection in vivo;mBio;2024-08-14

3. Cutaneous Applications of the Antiviral Drug Cidofovir: A Review;Journal of Clinical Medicine;2024-04-23

4. Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT;Bone Marrow Transplantation;2023-10-23

5. NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin;Molecular Pharmaceutics;2022-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3